• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

159.7900 USD 2.0300 1.29%

As of 20:04:05 ET on 09/17/2014.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 158.4000 High - Low: 161.1600 - 158.3800 Primary Exchange: NYSE Arca
Volume: 380,139 52-Week Range: 113.2201 - 172.5240 Beta vs SPSIBITR: 1.0003

ETF Chart for XBI

No chart data available.
  • XBI:US 159.7900
  • 1D
  • 1M
  • 1Y
157.7600
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2014-09-17) 159.7931
Assets (M) (on 2014-09-17) 1,238.3960
Shares out (M) 7.75
Market Cap (M) 1,238.37
% Premium -0.00
Average 52-Week % Premium -0.0119
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.67%

Performance for XBI

1-Month +2.86% 1-Year +24.11%
3-Month +6.04% 3-Year +36.22%
Year To Date +23.49% 5-Year +23.27%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 09/16/2014
Name Position Value % of Total
Puma Biotechnology Inc 261,479 71,498,818 5.742%
InterMune Inc 349,019 25,736,661 2.067%
Receptos Inc 387,024 23,681,999 1.902%
Anacor Pharmaceuticals Inc 948,644 23,507,398 1.888%
PTC Therapeutics Inc 615,191 22,276,066 1.789%
United Therapeutics Corp 173,194 21,997,370 1.766%
Gilead Sciences Inc 192,255 20,140,634 1.617%
Medivation Inc 207,062 20,066,378 1.611%
Pharmacyclics Inc 163,258 19,946,862 1.602%
Vertex Pharmaceuticals Inc 211,210 19,824,171 1.592%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil